bit.bio Stock
Bit.bio is a synthetic biology company that develops human cells for research, drug discovery, and cell therapy. Its proprietary opti-ox™ technology enables precise and scalable reprogramming of stem cells into any human cell type.
Founded: 2016
For more bit.bio stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Jonathan Milner Interim Chief Executive Officer |
| Kathryn Corzo President and Chief Operating Officer |
| Manos Metzakopian Chief Scientific Officer |
| Paul Morrill Chief Business Officer |
| Przemek Obloj Chief Financial Officer |
